Groowe / Newsroom / FDMT

⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

FDMT News

4D Molecular Therapeutics, Inc. Common Stock

4DMT Provides Company Update and Anticipated Development Milestones for 2026

globenewswire.com Jan 7, 2026 2:00 PM

4DMT Announces Positive Interim Clinical Data from 4D-710 AEROW Phase 1 Clinical Trial in Cystic Fibrosis Lung Disease

globenewswire.com Dec 17, 2025 1:00 PM

4DMT Announces New Employment Inducement Grants

globenewswire.com Dec 12, 2025 10:05 PM

4DMT to Present at the 44th Annual J.P. Morgan Healthcare Conference

globenewswire.com Dec 8, 2025 2:01 PM

NovaBridge’s Visara Subsidiary Appoints Distinguished Ophthalmology Leaders as Chief Medical Officer and Scientific Advisory Board Chair to Drive VIS-101 Forward

globenewswire.com Nov 21, 2025 11:47 AM

4DMT to Participate in 8th Annual Evercore Healthcare Conference

globenewswire.com Nov 20, 2025 2:02 PM

4DMT Appoints Kristian Humer as Chief Financial Officer

globenewswire.com Nov 17, 2025 12:00 PM

4DMT Announces New Employment Inducement Grants

globenewswire.com Nov 14, 2025 10:05 PM